Cargando…

Synthesis of nano-α mangostin based on chitosan and Eudragit S 100

Alpha-mangostin is a xanthone compound isolated from the mangosteen plant (Garcinia mangostana L.), which has various pharmacological activities. However, in its utilization alpha-mangostin is unstable and shows low solubility in the oral delivery system. Nanoparticles can deliver specific drugs to...

Descripción completa

Detalles Bibliográficos
Autores principales: Herdiana, Yedi, Handaresta, Devi Fitria, Joni, I. Made, Wathoni, Nasrul, Muchtaridi, Muchtaridi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574733/
https://www.ncbi.nlm.nih.gov/pubmed/33102191
http://dx.doi.org/10.4103/japtr.JAPTR_182_19
_version_ 1783597684005797888
author Herdiana, Yedi
Handaresta, Devi Fitria
Joni, I. Made
Wathoni, Nasrul
Muchtaridi, Muchtaridi
author_facet Herdiana, Yedi
Handaresta, Devi Fitria
Joni, I. Made
Wathoni, Nasrul
Muchtaridi, Muchtaridi
author_sort Herdiana, Yedi
collection PubMed
description Alpha-mangostin is a xanthone compound isolated from the mangosteen plant (Garcinia mangostana L.), which has various pharmacological activities. However, in its utilization alpha-mangostin is unstable and shows low solubility in the oral delivery system. Nanoparticles can deliver specific drugs to their workplace and increase the solubility. The objectives of this study were to create and characterize the alpha-mangostin nanoparticles based on chitosan and Eudragit® S 100. The nanoparticles were made by the ionic gelation method with comparisons core: Coating FI (1:2), FII (1:1), and FIII (2:1). Nanoparticles powder obtained using the spray pyrolysis method. Characterization using Fourier transform infrared indicates that the nanoparticles have been coated properly, and no damage occurred in the formula. The particle sizes for FI, FII, and FII are 373.381 ± 138.023 nm, 398.333 ± 184.977 nm, and 326.567 ± 130.366 nm, respectively, with a smooth surface. The entrapment efficiency value of FI, FII, and FIII are, respectively, 99.7692%, 99.6535%, and 99.476%. Alpha-mangostin was successfully encapsulated in chitosan-tripolyphosphate polymer by ionic gelation method and then coated with Eudragit S 100. Alpha-mangostin chitosan-eudragit nanoparticles (core: Polymer ratio of 1:2) yielded more entrapment efficiency.
format Online
Article
Text
id pubmed-7574733
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-75747332020-10-22 Synthesis of nano-α mangostin based on chitosan and Eudragit S 100 Herdiana, Yedi Handaresta, Devi Fitria Joni, I. Made Wathoni, Nasrul Muchtaridi, Muchtaridi J Adv Pharm Technol Res Original Article Alpha-mangostin is a xanthone compound isolated from the mangosteen plant (Garcinia mangostana L.), which has various pharmacological activities. However, in its utilization alpha-mangostin is unstable and shows low solubility in the oral delivery system. Nanoparticles can deliver specific drugs to their workplace and increase the solubility. The objectives of this study were to create and characterize the alpha-mangostin nanoparticles based on chitosan and Eudragit® S 100. The nanoparticles were made by the ionic gelation method with comparisons core: Coating FI (1:2), FII (1:1), and FIII (2:1). Nanoparticles powder obtained using the spray pyrolysis method. Characterization using Fourier transform infrared indicates that the nanoparticles have been coated properly, and no damage occurred in the formula. The particle sizes for FI, FII, and FII are 373.381 ± 138.023 nm, 398.333 ± 184.977 nm, and 326.567 ± 130.366 nm, respectively, with a smooth surface. The entrapment efficiency value of FI, FII, and FIII are, respectively, 99.7692%, 99.6535%, and 99.476%. Alpha-mangostin was successfully encapsulated in chitosan-tripolyphosphate polymer by ionic gelation method and then coated with Eudragit S 100. Alpha-mangostin chitosan-eudragit nanoparticles (core: Polymer ratio of 1:2) yielded more entrapment efficiency. Wolters Kluwer - Medknow 2020 2020-07-14 /pmc/articles/PMC7574733/ /pubmed/33102191 http://dx.doi.org/10.4103/japtr.JAPTR_182_19 Text en Copyright: © 2020 Journal of Advanced Pharmaceutical Technology & Research http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Herdiana, Yedi
Handaresta, Devi Fitria
Joni, I. Made
Wathoni, Nasrul
Muchtaridi, Muchtaridi
Synthesis of nano-α mangostin based on chitosan and Eudragit S 100
title Synthesis of nano-α mangostin based on chitosan and Eudragit S 100
title_full Synthesis of nano-α mangostin based on chitosan and Eudragit S 100
title_fullStr Synthesis of nano-α mangostin based on chitosan and Eudragit S 100
title_full_unstemmed Synthesis of nano-α mangostin based on chitosan and Eudragit S 100
title_short Synthesis of nano-α mangostin based on chitosan and Eudragit S 100
title_sort synthesis of nano-α mangostin based on chitosan and eudragit s 100
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574733/
https://www.ncbi.nlm.nih.gov/pubmed/33102191
http://dx.doi.org/10.4103/japtr.JAPTR_182_19
work_keys_str_mv AT herdianayedi synthesisofnanoamangostinbasedonchitosanandeudragits100
AT handarestadevifitria synthesisofnanoamangostinbasedonchitosanandeudragits100
AT joniimade synthesisofnanoamangostinbasedonchitosanandeudragits100
AT wathoninasrul synthesisofnanoamangostinbasedonchitosanandeudragits100
AT muchtaridimuchtaridi synthesisofnanoamangostinbasedonchitosanandeudragits100